IRRAS introduces Hummingbird ICP monitoring deviceFebruary 5, 2020
IRRAS has launched Hummingbird intracranial pressure (ICP) monitoring product family in the United States.
These products, which were acquired by IRRAS in May 2019, include proprietary single and multi-lumen cranial access bolts, parenchymal ICP monitoring, and a cranial access kit.
The Hummingbird family of products helps clinicians diagnose and manage patients’ intracranial pressure after traumatic brain injury, a subarachnoid haemorrhage, and/or a stroke. The Hummingbird ICP monitoring product line is designed for accuracy, reliability, and ease of use to address the needs of both the hospital and the patient, IRRAS said.
“From the diagnosis of traumatic brain injury to needed drainage that removes the blood and reduces excess pressure, Hummingbird and IRRA flow bring needed innovation to the entire spectrum of neurocritical care,” said Will Martin, chief commercial officer of IRRAS, in a statement.